10-Q Filing

CVS HEALTH CORP CIK: 64803 Q2 2021

Filing Information

Form Type	10-Q
Accession Number	`0000064803-21-000028`
Period End Date	20210630
Filing Date	20210804
Fiscal Year	2021
Fiscal Period	Q2
XBRL Instance	cvs-20210630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 100 Income Statement 82 Cash Flow Statement 78 Stockholders Equity 60 Comprehensive Income 40

Balance Sheet 100 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$7.85B	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$7.12B	USD	Point-in-time
Investments	`ShortTermInvestments`	$3.00B	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Investments	`ShortTermInvestments`	$3.01B	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$24.16B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$21.74B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$18.50B	USD	Point-in-time
Inventories	`InventoryNet`	$16.98B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$5.28B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$5.29B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$56.37B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$56.56B	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	1.74B	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	1.73B	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.32B	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.31B	shares	Point-in-time
Long-term investments	`LongTermInvestments`	$22.14B	USD	Point-in-time
Long-term investments	`LongTermInvestments`	$20.81B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.66B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.61B	USD	Point-in-time
Treasury stock (in shares)	`TreasuryStockShares`	424.00M	shares	Point-in-time
Treasury stock (in shares)	`TreasuryStockShares`	423.00M	shares	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$20.73B	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$20.48B	USD	Point-in-time
Goodwill	`Goodwill`	$79.55B	USD	Point-in-time
Goodwill	`Goodwill`	$79.55B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$31.14B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$30.08B	USD	Point-in-time
Separate accounts assets	`SeparateAccountAssets`	$4.88B	USD	Point-in-time
Separate accounts assets	`SeparateAccountAssets`	$4.88B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.62B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.82B	USD	Point-in-time
Total assets	`Assets`	$230.72B	USD	Point-in-time
Total assets	`Assets`	$231.16B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$11.05B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$11.14B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsandDiscountsPayableCurrent`	$15.79B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsandDiscountsPayableCurrent`	$17.23B	USD	Point-in-time
Health care costs payable	`LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet`	$7.94B	USD	Point-in-time
Health care costs payable	`LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet`	$8.41B	USD	Point-in-time
Policyholders funds	`OtherPolicyholderFunds`	$4.27B	USD	Point-in-time
Policyholders funds	`OtherPolicyholderFunds`	$4.57B	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$14.83B	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$14.24B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$1.56B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$1.38B	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.79B	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.64B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$60.00M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$5.44B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$62.02B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$59.31B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$18.76B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$18.51B	USD	Point-in-time
Long-term debt	`LongTermDebtAndCapitalLeaseObligations`	$59.29B	USD	Point-in-time
Long-term debt	`LongTermDebtAndCapitalLeaseObligations`	$59.21B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$6.79B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$6.56B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$4.88B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$4.88B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$6.73B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$7.01B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$2.31B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$2.35B	USD	Point-in-time
Total liabilities	`Liabilities`	$157.60B	USD	Point-in-time
Total liabilities	`Liabilities`	$161.01B	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,742 shares issued and 1,318 shares outstanding at June 30, 2021 and 1,733 shares issued and 1,310 shares outstanding at December 31, 2020 and capital surplus	`CommonStocksIncludingAdditionalPaidInCapital`	$46.51B	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,742 shares issued and 1,318 shares outstanding at June 30, 2021 and 1,733 shares issued and 1,310 shares outstanding at December 31, 2020 and capital surplus	`CommonStocksIncludingAdditionalPaidInCapital`	$46.99B	USD	Point-in-time
Treasury stock, at cost: 424 shares at June 30, 2021 and 423 shares at December 31, 2020	`TreasuryStockValue`	$28.18B	USD	Point-in-time
Treasury stock, at cost: 424 shares at June 30, 2021 and 423 shares at December 31, 2020	`TreasuryStockValue`	$28.25B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$49.64B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$53.33B	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.41B	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.17B	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$73.24B	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$69.39B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$321.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$312.00M	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$73.56B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.16B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$69.70B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$68.36B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$65.47B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$64.17B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$230.72B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$231.16B	USD	Point-in-time

Income Statement 82 line items

Line Item	Tag	Value	Unit	Period
Premiums	`PremiumsEarnedNet`	$18.98B	USD	1 Quarter
Premiums	`PremiumsEarnedNet`	$34.57B	USD	2 Qtrs
Premiums	`PremiumsEarnedNet`	$16.93B	USD	1 Quarter
Premiums	`PremiumsEarnedNet`	$37.94B	USD	2 Qtrs
Net investment income	`NetInvestmentIncome`	$346.00M	USD	2 Qtrs
Net investment income	`NetInvestmentIncome`	$184.00M	USD	1 Quarter
Net investment income	`NetInvestmentIncome`	$289.00M	USD	1 Quarter
Net investment income	`NetInvestmentIncome`	$586.00M	USD	2 Qtrs
Total revenues	`Revenues`	$141.71B	USD	2 Qtrs
Total revenues	`Revenues`	$65.34B	USD	1 Quarter
Total revenues	`Revenues`	$132.10B	USD	2 Qtrs
Total revenues	`Revenues`	$72.62B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$43.52B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$84.41B	USD	2 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$40.24B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$80.59B	USD	2 Qtrs
Benefit costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$11.75B	USD	1 Quarter
Benefit costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$26.14B	USD	2 Qtrs
Benefit costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$31.61B	USD	2 Qtrs
Benefit costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$15.90B	USD	1 Quarter
Operating expenses	`OperatingExpenses`	$17.23B	USD	2 Qtrs
Operating expenses	`OperatingExpenses`	$8.67B	USD	1 Quarter
Operating expenses	`OperatingExpenses`	$17.79B	USD	2 Qtrs
Operating expenses	`OperatingExpenses`	$8.87B	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$68.29B	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$60.66B	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$123.96B	USD	2 Qtrs
Total operating costs	`CostsAndExpenses`	$133.81B	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$4.33B	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$7.90B	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$4.68B	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$8.14B	USD	2 Qtrs
Interest expense	`InterestExpense`	$636.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$765.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$1.29B	USD	2 Qtrs
Interest expense	`InterestExpense`	$1.50B	USD	2 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$45.00M	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$99.00M	USD	2 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$95.00M	USD	2 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$45.00M	USD	1 Quarter
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$6.71B	USD	2 Qtrs
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$3.96B	USD	1 Quarter
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$3.73B	USD	1 Quarter
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$6.74B	USD	2 Qtrs
Income tax provision	`IncomeTaxExpenseBenefit`	$974.00M	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$1.69B	USD	2 Qtrs
Income tax provision	`IncomeTaxExpenseBenefit`	$1.74B	USD	2 Qtrs
Income tax provision	`IncomeTaxExpenseBenefit`	$944.00M	USD	1 Quarter
Net income	`ProfitLoss`	$2.01B	USD	1 Quarter
Net income	`ProfitLoss`	$5.00B	USD	2 Qtrs
Net income	`ProfitLoss`	$2.99B	USD	1 Quarter
Net income	`ProfitLoss`	$5.01B	USD	2 Qtrs
Net income	`ProfitLoss`	$2.79B	USD	1 Quarter
Net income	`ProfitLoss`	$2.22B	USD	1 Quarter
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$8.00M	USD	1 Quarter
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$9.00M	USD	2 Qtrs
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$11.00M	USD	1 Quarter
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$16.00M	USD	2 Qtrs
Net income attributable to CVS Health	`NetIncomeLoss`	$4.98B	USD	2 Qtrs
Net income attributable to CVS Health	`NetIncomeLoss`	$5.01B	USD	2 Qtrs
Net income attributable to CVS Health	`NetIncomeLoss`	$2.78B	USD	1 Quarter
Net income attributable to CVS Health	`NetIncomeLoss`	$2.98B	USD	1 Quarter
Net income per share attributable to CVS Health, basic (in dollars per share)	`EarningsPerShareBasic`	$3.80	USD	2 Qtrs
Net income per share attributable to CVS Health, basic (in dollars per share)	`EarningsPerShareBasic`	$3.81	USD	2 Qtrs
Net income per share attributable to CVS Health, basic (in dollars per share)	`EarningsPerShareBasic`	$2.11	USD	1 Quarter
Net income per share attributable to CVS Health, basic (in dollars per share)	`EarningsPerShareBasic`	$2.27	USD	1 Quarter
Net income per share attributable to CVS Health, diluted (in dollars per share)	`EarningsPerShareDiluted`	$2.10	USD	1 Quarter
Net income per share attributable to CVS Health, diluted (in dollars per share)	`EarningsPerShareDiluted`	$2.26	USD	1 Quarter
Net income per share attributable to CVS Health, diluted (in dollars per share)	`EarningsPerShareDiluted`	$3.78	USD	2 Qtrs
Net income per share attributable to CVS Health, diluted (in dollars per share)	`EarningsPerShareDiluted`	$3.79	USD	2 Qtrs
Weighted average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.31B	shares	1 Quarter
Weighted average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.32B	shares	1 Quarter
Weighted average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.32B	shares	2 Qtrs
Weighted average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.31B	shares	2 Qtrs
Weighted average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.32B	shares	2 Qtrs
Weighted average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.31B	shares	1 Quarter
Weighted average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.31B	shares	2 Qtrs
Weighted average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.33B	shares	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$1.00	USD	2 Qtrs
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.50	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$1.00	USD	2 Qtrs
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.50	USD	1 Quarter

Cash Flow Statement 78 line items

Line Item	Tag	Value	Unit	Period
Cash receipts from customers	`ProceedsFromCustomers`	$129.22B	USD	2 Qtrs
Cash receipts from customers	`ProceedsFromCustomers`	$136.62B	USD	2 Qtrs
Cash paid for inventory and prescriptions dispensed by retail network pharmacies	`PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies`	$79.32B	USD	2 Qtrs
Cash paid for inventory and prescriptions dispensed by retail network pharmacies	`PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies`	$76.38B	USD	2 Qtrs
Insurance benefits paid	`PaymentsforInsuranceBenefits`	$26.48B	USD	2 Qtrs
Insurance benefits paid	`PaymentsforInsuranceBenefits`	$31.25B	USD	2 Qtrs
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$14.90B	USD	2 Qtrs
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$14.69B	USD	2 Qtrs
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$394.00M	USD	2 Qtrs
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$395.00M	USD	2 Qtrs
Interest paid	`InterestPaidNet`	$1.41B	USD	2 Qtrs
Interest paid	`InterestPaidNet`	$1.26B	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$230.00M	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$1.55B	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$8.74B	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$10.42B	USD	2 Qtrs
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$3.95B	USD	2 Qtrs
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$2.71B	USD	2 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$3.69B	USD	2 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$5.57B	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.19B	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.31B	USD	2 Qtrs
Acquisitions (net of cash acquired)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$108.00M	USD	2 Qtrs
Acquisitions (net of cash acquired)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$768.00M	USD	2 Qtrs
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-72.00M	USD	2 Qtrs
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-6.00M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-2.93B	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-2.97B	USD	2 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$3.95B	USD	2 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	2 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$5.42B	USD	2 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$1.02B	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$1.31B	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$1.31B	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$166.00M	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$330.00M	USD	2 Qtrs
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$68.00M	USD	2 Qtrs
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$159.00M	USD	2 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	-	USD	2 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-16.00M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-6.56B	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.70B	USD	2 Qtrs
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$9.19B	USD	2 Qtrs
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-793.00M	USD	2 Qtrs
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.13B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.34B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.95B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$15.14B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.13B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.34B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.95B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$15.14B	USD	Point-in-time
Net income	`ProfitLoss`	$2.01B	USD	1 Quarter
Net income	`ProfitLoss`	$5.00B	USD	2 Qtrs
Net income	`ProfitLoss`	$2.99B	USD	1 Quarter
Net income	`ProfitLoss`	$5.01B	USD	2 Qtrs
Net income	`ProfitLoss`	$2.79B	USD	1 Quarter
Net income	`ProfitLoss`	$2.22B	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$2.26B	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$2.19B	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$179.00M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$232.00M	USD	2 Qtrs
Deferred income taxes and other noncash items	`Deferredincometaxesandothernoncashitems`	$-370.00M	USD	2 Qtrs
Deferred income taxes and other noncash items	`Deferredincometaxesandothernoncashitems`	$-101.00M	USD	2 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$2.23B	USD	2 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$2.38B	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$-1.52B	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$-1.00B	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$560.00M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$145.00M	USD	2 Qtrs
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$1.67B	USD	2 Qtrs
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$1.70B	USD	2 Qtrs
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$-415.00M	USD	2 Qtrs
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$104.00M	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$3.69B	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$805.00M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$8.74B	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$10.42B	USD	2 Qtrs

Stockholders Equity 60 line items

Line Item	Tag	Value	Unit	Period
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury share held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury share held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury share held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury share held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury share held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury share held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$17.00M	USD	Point-in-time
Decrease in retained earnings	`RetainedEarningsAccumulatedDeficit`	$49.64B	USD	Point-in-time
Decrease in retained earnings	`RetainedEarningsAccumulatedDeficit`	$53.33B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$73.56B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.16B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$69.70B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$68.36B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$65.47B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$64.17B	USD	Point-in-time
Net income	`ProfitLoss`	$2.01B	USD	1 Quarter
Net income	`ProfitLoss`	$5.00B	USD	2 Qtrs
Net income	`ProfitLoss`	$2.99B	USD	1 Quarter
Net income	`ProfitLoss`	$5.01B	USD	2 Qtrs
Net income	`ProfitLoss`	$2.79B	USD	1 Quarter
Net income	`ProfitLoss`	$2.22B	USD	1 Quarter
Other comprehensive Income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$194.00M	USD	2 Qtrs
Other comprehensive Income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$148.00M	USD	1 Quarter
Other comprehensive Income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-244.00M	USD	2 Qtrs
Other comprehensive Income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-332.00M	USD	1 Quarter
Other comprehensive Income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$526.00M	USD	1 Quarter
Other comprehensive Income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-392.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$268.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$96.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$214.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$208.00M	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$150.00M	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$53.00M	USD	1 Quarter
ESPP issuances, net of purchase of treasury shares	`ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod`	$76.00M	USD	1 Quarter
ESPP issuances, net of purchase of treasury shares	`ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod`	$53.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$660.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$655.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$662.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$657.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollinginterestOtherPeriodIncreaseDecrease`	$-1.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollinginterestOtherPeriodIncreaseDecrease`	$1.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollinginterestOtherPeriodIncreaseDecrease`	$-12.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollinginterestOtherPeriodIncreaseDecrease`	$23.00M	USD	1 Quarter
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$73.56B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.16B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$69.70B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$68.36B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$65.47B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$64.17B	USD	Point-in-time

Comprehensive Income 40 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$2.01B	USD	1 Quarter
Net income	`ProfitLoss`	$5.00B	USD	2 Qtrs
Net income	`ProfitLoss`	$2.99B	USD	1 Quarter
Net income	`ProfitLoss`	$5.01B	USD	2 Qtrs
Net income	`ProfitLoss`	$2.79B	USD	1 Quarter
Net income	`ProfitLoss`	$2.22B	USD	1 Quarter
Net unrealized investment gains (losses)	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$149.00M	USD	1 Quarter
Net unrealized investment gains (losses)	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$524.00M	USD	1 Quarter
Net unrealized investment gains (losses)	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$213.00M	USD	2 Qtrs
Net unrealized investment gains (losses)	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-237.00M	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-6.00M	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$6.00M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$1.00M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.00M	USD	2 Qtrs
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-12.00M	USD	2 Qtrs
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-3.00M	USD	1 Quarter
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-3.00M	USD	1 Quarter
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-7.00M	USD	2 Qtrs
Pension and other postretirement benefits	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$1.00M	USD	2 Qtrs
Pension and other postretirement benefits	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-1.00M	USD	1 Quarter
Pension and other postretirement benefits	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$1.00M	USD	1 Quarter
Pension and other postretirement benefits	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-1.00M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$194.00M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$148.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-244.00M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-332.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$526.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-392.00M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$3.51B	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$4.77B	USD	2 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$5.19B	USD	2 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$2.94B	USD	1 Quarter
Comprehensive income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$8.00M	USD	1 Quarter
Comprehensive income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$9.00M	USD	2 Qtrs
Comprehensive income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$11.00M	USD	1 Quarter
Comprehensive income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$16.00M	USD	2 Qtrs
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$4.76B	USD	2 Qtrs
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$3.50B	USD	1 Quarter
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$5.18B	USD	2 Qtrs
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$2.93B	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.